{"id":5891,"date":"2022-05-11T10:00:00","date_gmt":"2022-05-11T10:00:00","guid":{"rendered":"https:\/\/genekor.dermtherapy.gr\/2023\/12\/07\/recomandari-asco-actualizate\/"},"modified":"2024-03-04T08:08:46","modified_gmt":"2024-03-04T08:08:46","slug":"recomandari-asco-actualizate","status":"publish","type":"post","link":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/","title":{"rendered":"Recomand\u0103ri ASCO actualizate!"},"content":{"rendered":"\n<p>Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi.<\/p>\n\n\n\n<p><strong>ASCO<\/strong><strong>\u00ae<\/strong> \u0219i-a actualizat ghidurile privind biomarkerii pentru endocrinul adjuvant \u0219i chimioterapia \u00een cancerul de s\u00e2n \u00een stadiu incipient.<\/p>\n\n\n\n<p>Ghidurile <strong>ASCO<\/strong> recomand\u0103 acum cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n \u00een stadiu incipient HR+, HER2 cu ganglioni negativi \u0219i postmenopauz\u0103 pozitivi1.<\/p>\n\n\n\n<p>Pentru pacien\u021bii \u00een premenopauz\u0103 cu ganglioni negativi, testul <strong>Oncotype<\/strong> <strong>DX<\/strong><strong>\u00ae<\/strong> este singurul test recomandat. Recomandarea este ampl\u0103 \u0219i indiferent de orice clasificare a riscului clinic.<\/p>\n\n\n\n<p>\u00cen plus, testul <strong>Oncotype DX\u00ae<\/strong> este cel mai recomandat cu cea mai \u00eenalt\u0103 calitate a dovezilor dintre toate testele genomice incluse \u00een ghid.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"525\" src=\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/2bc13dd7-f8f9-3e35-d8c4-8a47188a5316-1024x525.png\" alt=\"\" class=\"wp-image-5902\" srcset=\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/2bc13dd7-f8f9-3e35-d8c4-8a47188a5316-1024x525.png 1024w, https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/2bc13dd7-f8f9-3e35-d8c4-8a47188a5316-300x154.png 300w, https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/2bc13dd7-f8f9-3e35-d8c4-8a47188a5316-768x394.png 768w, https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/2bc13dd7-f8f9-3e35-d8c4-8a47188a5316-1536x787.png 1536w, https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/2bc13dd7-f8f9-3e35-d8c4-8a47188a5316.png 1697w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Dup\u0103 cum a fost publicat: <br>1. <strong>SINGURUL<\/strong> test recomandat pentru utilizare la pacientii in premenopauza cu N0 este <strong>Oncotype DX\u00ae<\/strong>!!!<\/p>\n\n\n\n<p>2. De asemenea, pentru pacientele aflate \u00een postmenopauz\u0103, <strong>Oncotype DX\u00ae<\/strong> este <strong>SINGURUL<\/strong> cu dovezi de \u00eenalt\u0103 calitate \u0219i recomandare puternic\u0103.<\/p>\n\n\n\n<p>3. Mammaprint are o not\u0103 de subsol (a) care spune c\u0103 este <strong>NUMAI<\/strong> pentru femeile cu risc clinic ridicat, ceea ce \u00eenseamn\u0103 c\u0103 NU este indicat pentru pacien\u021bii cu cancer de gradul 1 \u0219i mai mic de 3 cm, gradul 2 \u0219i mai mic de 2 cm \u0219i gradul 3 \u0219i mai mic de 1 cm.<\/p>\n\n\n\n<p>4. EndoPredict <strong>NU<\/strong> este recomandat la pacien\u021bii \u00een premenopauz\u0103 \u0219i la pacien\u021bii \u00een postmenopauz\u0103 at\u00e2t \u00een \u200b\u200bN0 c\u00e2t \u0219i \u00een N1, puterea recomand\u0103rii este moderat\u0103 \u0219i NU puternic\u0103, datorit\u0103 calit\u0103\u021bii intermediare a dovezilor \u0219i lipsei oric\u0103ror date prospective.<\/p>\n\n\n\n<p>5. Prosigna <strong>NU<\/strong> este indicat\u0103 pentru pacien\u021bii cu ganglioni pozitivi, a\u0219a c\u0103 indica\u021bia este potrivit\u0103 NUMAI pentru pacien\u021bii cu ganglioni negativi \u00een postmenopauz\u0103.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><br><strong>G\u0103si\u021bi mai jos lucrarea:<br><a href=\"https:\/\/ascopubs.org\/doi\/full\/10.1200\/JCO.22.00069\">Biomarkeri pentru adjuvant endocrin \u0219i chimioterapie \u00een cancerul de s\u00e2n \u00een stadiu incipient: actualizarea ghidurilor ASCO<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi. ASCO\u00ae [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5892,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33],"tags":[],"class_list":["post-5891","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-ro"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.0 (Yoast SEO v24.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Recomand\u0103ri ASCO actualizate! - Genekor<\/title>\n<meta name=\"description\" content=\"Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recomand\u0103ri ASCO actualizate!\" \/>\n<meta property=\"og:description\" content=\"Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-11T10:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-04T08:08:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Vassia Lagou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Vassia Lagou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/\"},\"author\":{\"name\":\"Vassia Lagou\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9\"},\"headline\":\"Recomand\u0103ri ASCO actualizate!\",\"datePublished\":\"2022-05-11T10:00:00+00:00\",\"dateModified\":\"2024-03-04T08:08:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/\"},\"wordCount\":318,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png\",\"articleSection\":[\"Uncategorized @ro\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/\",\"url\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/\",\"name\":\"Recomand\u0103ri ASCO actualizate! - Genekor\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png\",\"datePublished\":\"2022-05-11T10:00:00+00:00\",\"dateModified\":\"2024-03-04T08:08:46+00:00\",\"description\":\"Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi.\",\"breadcrumb\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png\",\"width\":1920,\"height\":1080,\"caption\":\"oncotype dx breast recurrence score\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genekor.com\/ro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recomand\u0103ri ASCO actualizate!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekor.com\/ro\/#website\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"name\":\"Genekor\",\"description\":\"Medicina personalizat\u0103\",\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekor.com\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/genekor.com\/ro\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/genekorbiotechnology\/\",\"https:\/\/gr.linkedin.com\/company\/genekor-sa\",\"https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9\",\"name\":\"Vassia Lagou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g\",\"caption\":\"Vassia Lagou\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Recomand\u0103ri ASCO actualizate! - Genekor","description":"Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/","og_locale":"ro_RO","og_type":"article","og_title":"Recomand\u0103ri ASCO actualizate!","og_description":"Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi.","og_url":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2022-05-11T10:00:00+00:00","article_modified_time":"2024-03-04T08:08:46+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png","type":"image\/png"}],"author":"Vassia Lagou","twitter_card":"summary_large_image","twitter_misc":{"Scris de":"Vassia Lagou","Timp estimat pentru citire":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/"},"author":{"name":"Vassia Lagou","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9"},"headline":"Recomand\u0103ri ASCO actualizate!","datePublished":"2022-05-11T10:00:00+00:00","dateModified":"2024-03-04T08:08:46+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/"},"wordCount":318,"commentCount":0,"publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"image":{"@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png","articleSection":["Uncategorized @ro"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/","url":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/","name":"Recomand\u0103ri ASCO actualizate! - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png","datePublished":"2022-05-11T10:00:00+00:00","dateModified":"2024-03-04T08:08:46+00:00","description":"Ghidurile ASCO actualizate recomand\u0103 cu t\u0103rie utilizarea testului Oncotype DX Breast Recurrence Score\u00ae la pacien\u021bii cu cancer de s\u00e2n cu ganglioni negativi \u0219i \u00een faza incipient\u0103 cu ganglioni pozitivi.","breadcrumb":{"@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/updatedascoguidelines.png","width":1920,"height":1080,"caption":"oncotype dx breast recurrence score"},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/ro\/2022\/05\/11\/recomandari-asco-actualizate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/ro\/"},{"@type":"ListItem","position":2,"name":"Recomand\u0103ri ASCO actualizate!"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/ro\/#website","url":"https:\/\/genekor.com\/ro\/","name":"Genekor","description":"Medicina personalizat\u0103","publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/genekor.com\/ro\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/ro\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9","name":"Vassia Lagou","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g","caption":"Vassia Lagou"}}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/5891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/comments?post=5891"}],"version-history":[{"count":6,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/5891\/revisions"}],"predecessor-version":[{"id":9002,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/5891\/revisions\/9002"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media\/5892"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media?parent=5891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/categories?post=5891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/tags?post=5891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}